Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.
about
Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccinesAvian influenza virus (H5N1): a threat to human health.Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccineAdenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5Novel viral vectored vaccines for the prevention of influenza.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesImmunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin.Assessment of route of administration and dose escalation for an adenovirus-based influenza A Virus (H5N1) vaccine in chickensImproved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses.Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1.A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.Chicken Anti-Campylobacter Vaccine - Comparison of Various Carriers and Routes of Immunization.The prevention and control of avian influenza: the avian influenza coordinated agriculture project.Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs.Immune Responses Induced by Recombinant Bacillus Subtilis Expressing the Hemagglutinin Protein of H5N1 in chickensStrategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza.Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases.Progress on adenovirus-vectored universal influenza vaccines.Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses.Immune responses of chickens inoculated with recombinant Lactobacillus expressing the haemagglutinin of the avian influenza virus.Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.Layer chicken embryo survival to hatch when administered an in ovo vaccination of strain F Mycoplasma gallisepticum and locations of bacteria prevalence in the newly hatched chick.Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine.Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions
P2860
Q27013568-C6E434B3-56CB-4E02-92D3-411BCF1127FCQ30361041-6F3C0A74-10AB-4AC8-90DA-86BBF4E7A86FQ30368615-7F608FFD-9C56-4AAB-954F-6FE9DC97FD9EQ30375982-2FEEEBAA-B59C-43AD-A89D-46294B983C1CQ30389956-0E0DBB31-874C-46A7-AE2D-6467D3557A0CQ30418570-5A4C5F68-71F4-499D-B6A7-7E92BDDD3AA7Q30427591-39F3C134-8D9D-4217-86AB-E77D997AA11FQ33490614-78EA3816-61CA-4F70-A7B7-9A134B55B2F1Q34096950-47D4A027-9855-4A01-A1E4-4F7FCCB3A9BDQ34150488-87600E83-7571-405D-B73E-28E6EF8B6598Q34547300-A0E946C8-78B2-4C7D-91DF-E411DD47EDF5Q35739107-88415BDA-A79A-4477-9D80-996002A22074Q35947906-F7B102B4-36D8-4F74-AC35-74C8879DCB33Q36837166-527B425F-194D-4CF2-B3A6-10A86309EB8FQ36915598-C46E417C-5DDC-4683-B134-65C4C7F2E442Q37167450-607A9062-7145-44C5-A9A8-2D5C84D2EDBBQ37280943-CEBE2499-9410-4A44-8224-5AAB379654D7Q37508244-F5641BF2-EF7F-4D93-A30A-A22E29EAF49EQ37658883-2B2C61CA-BE12-4DF5-9F48-5D04D96F228AQ37951524-1DE2BEB8-2BF2-449F-9B15-29249EF5F7E3Q38421971-963DA07C-31C2-4C6E-9861-762A445B1D51Q39565371-D25B060D-CB81-445F-A3B3-6A0E969AF8B9Q42277270-7B1D6190-43A5-4A63-9D55-C1ED763284BEQ42451182-16E1E75C-6CBF-433D-B1B5-97ED6D08AA71Q47639914-259E4E14-5B9D-420D-9D7C-1D9DBFE0100EQ47927986-499CE276-70C5-4200-83E1-E64142ED5E07Q55517916-E09BE196-1457-44F4-8498-F06B28F6EDD7Q56892183-67746329-0070-4A7A-B610-AEDD7948D223
P2860
Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Protective avian influenza in ...... ating human adenovirus vector.
@en
Protective avian influenza in ...... ating human adenovirus vector.
@nl
type
label
Protective avian influenza in ...... ating human adenovirus vector.
@en
Protective avian influenza in ...... ating human adenovirus vector.
@nl
prefLabel
Protective avian influenza in ...... ating human adenovirus vector.
@en
Protective avian influenza in ...... ating human adenovirus vector.
@nl
P2093
P2860
P1433
P1476
Protective avian influenza in ...... cating human adenovirus vector
@en
P2093
De-chu C Tang
Haroldo Toro
Jennifer Pfeiffer
Kent R Van Kampen
P2860
P304
P356
10.1016/J.VACCINE.2006.09.047
P407
P577
2006-09-25T00:00:00Z